An Analysis of Dasatinib Treatment Patterns in Patients with Chronic Myeloid Leukemia After Experiencing Pleural Effusion During Dasatinib Therapy.

Ali McBride,John Brokars,Sheila Reiss Reddy,Eunice Chang,Marian H Tarbox,Thomas W LeBlanc

Acta haematologica（2023）

引用 0|浏览13

暂无评分

摘要

Dasatinib dose modification after pleural effusion was not always required; however, patients with dose modifications continued therapy for a longer duration with a lower rate of switching to another TKI versus patients who remained on a stable dose.

查看译文

关键词

Chronic myeloid leukemia, Hematological malignancies, Malignant hematology

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要